醛氧化酶
药品
药物发现
化学
新陈代谢
醛
药理学
酶
组合化学
药物代谢
生物化学
医学
催化作用
黄嘌呤氧化酶
作者
Nenad Manevski,Lloyd M. King,William R. Pitt,Fabien Lecomte,Francesca Toselli
标识
DOI:10.1021/acs.jmedchem.9b00875
摘要
Aldehyde oxidase (AO) catalyzes oxidations of azaheterocycles and aldehydes, amide hydrolysis, and diverse reductions. AO substrates are rare among marketed drugs, and many candidates failed due to poor pharmacokinetics, interspecies differences, and adverse effects. As most issues arise from complex and poorly understood AO biology, an effective solution is to stop or decrease AO metabolism. This perspective focuses on rational drug design approaches to modulate AO-mediated metabolism in drug discovery. AO biological aspects are also covered, as they are complementary to chemical design and important when selecting the experimental system for risk assessment. The authors' recommendation is an early consideration of AO-mediated metabolism supported by computational and in vitro experimental methods but not an automatic avoidance of AO structural flags, many of which are versatile and valuable building blocks. Preferably, consideration of AO-mediated metabolism should be part of the multiparametric drug optimization process, with the goal to improve overall drug-like properties.
科研通智能强力驱动
Strongly Powered by AbleSci AI